IBM at US$237.75 trades below DCF on IBM Z probe

IBM's recent history for long-term holders has been a strong run, with the stock returning 120.4% over the past five years. That performance has put a lot of accumulated optimism on the line, and after a sharp setback this year the question has shifted to whether the current US$237.75 share price still lines up with the cash the company is expected to generate.

The discounted cash flow view used here values IBM on cash flows that already look sizeable, with latest twelve month free cash flow of about $13.1b. The projections lean on growing free cash flow rather than a turnaround story, which fits a business already throwing off significant cash rather than one trying to claw back from losses.

What is keeping the shares below that implied value, according to this framing, is the investigation into the IBM Z shortfall. Investors may want clearer evidence on the resilience of future cash streams before closing the gap, and fresh commitments around quantum hardware, AI governance products and regulatory partnerships could shape how they think about the timing and scale of investment needed before those areas contribute meaningfully. The near-term read likely hinges on how the IBM Z matter resolves and whether IBM can show steady conversion of its AI, quantum and software efforts into cash.